Craig Ostroff Email & Phone Number

Craig Ostroff Work

• 2024 -now Vice President Regulatory Affairs @ Seaport Therapeutics
• 2023 -now BioMarker Data Repository, Charter and Governance Committee Board Member @ Critical Path Institute (C-Path)
• 2022 -now CEO @ Mill Street Consulting LLC, A biotech and start-up focused practice
• 2022 -2024 Interim Head of Regulatory Affairs and QA (Consultant) @ Protagonist Therapeutics
• 2020 -2022 Vice President and Head, Regulatory Affairs and Quality Assurance @ Goldfinch Bio
• 2016 -2020 Vice President, Global Head, CV, Metabolism, Renal and Retinal Gene Therapy, Global Regulatory Affairs @ Johnson & Johnson
• 2012 -2016 Senior Director, Cardio-Renal, Dermatology and also Early Development, Global Regulatory Affairs @ Otsuka Pharmaceutical Companies (U.S.)
• 2006 -2015 Secretary of the Executive Committee, Board of Trustees @ NEW JERSEY SCHOLARS PROGRAM INC
• 2011 -2012 Senior Director, Head, US Regulatory Affairs @ Archimedes Pharma
• 2011 -2011 Fellow (Established Scientist) @ ORAU
• 2010 -2011 Managing Director @ CORE Regulatory Consulting LLC
• 2008 -2010 Senior Director, Group Leader, CNS, Worldwide Regulatory Affairs @ Cephalon
• 2008 -2009 Senior Director, Group Leader, Pain Therapy Area, Worldwide Regulatory Affairs @ Cephalon
• 2005 -2008 Associate Director and Liaison, Global Regulatory Affairs @ Schering-Plough Research Institute
• 2003 -2005 Associate Director and Liaison, Global Regulatory Affairs @ Sanofi
• 2002 -2003 Lecturer @ The Johns Hopkins University
• 2000 -2003 Regulatory Management Officer, CDER, Division of Pulmonary and Allergy Drug Products @ FDA
• 1997 -2000 Regulatory Project Manager @ Harris FRC